210 related articles for article (PubMed ID: 19557318)
1. Predictors of pregnancy outcome in antiphospholipid syndrome: a review.
De Carolis S; Botta A; Santucci S; Garofalo S; Martino C; Perrelli A; Salvi S; Ferrazzani S; Caforio L; Scambia G
Clin Rev Allergy Immunol; 2010 Apr; 38(2-3):116-24. PubMed ID: 19557318
[TBL] [Abstract][Full Text] [Related]
2. Uterine artery velocity waveforms as predictors of pregnancy outcome in patients with antiphospholipid syndrome: a review.
De Carolis S; Botta A; Garofalo S; Ferrazzani S; Martino C; Fatigante G; Caforio L; Caruso A
Ann N Y Acad Sci; 2007 Jun; 1108():530-9. PubMed ID: 17894018
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome.
De Carolis S; Tabacco S; Rizzo F; Giannini A; Botta A; Salvi S; Garufi C; Benedetti Panici P; Lanzone A
Autoimmun Rev; 2018 Oct; 17(10):956-966. PubMed ID: 30118899
[TBL] [Abstract][Full Text] [Related]
4. Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women.
De Carolis S; Tabacco S; Rizzo F; Perrone G; Garufi C; Botta A; Salvi S; Benedetti Panici P; Lanzone A
Lupus; 2018 Apr; 27(5):841-846. PubMed ID: 29157179
[TBL] [Abstract][Full Text] [Related]
5. Anticardiolipin Positivity Is Highly Associated With Intrauterine Growth Restriction in Women With Antiphospholipid Syndrome.
Xi F; Cai Y; Lv M; Jiang Y; Zhou F; Chen Y; Jiang L; Luo Q
Clin Appl Thromb Hemost; 2020; 26():1076029620974455. PubMed ID: 33296221
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome.
Caruso A; De Carolis S; Ferrazzani S; Valesini G; Caforio L; Mancuso S
Obstet Gynecol; 1993 Dec; 82(6):970-7. PubMed ID: 8233274
[TBL] [Abstract][Full Text] [Related]
7. The relationship between TORCH complex false positivity and obstetric outcome in patients with antiphospholipid syndrome.
De Carolis S; Santucci S; Botta A; Salvi S; Degennaro VA; Garufi C; Garofalo S; Ferrazzani S; Scambia G
Lupus; 2012 Jun; 21(7):773-5. PubMed ID: 22635229
[TBL] [Abstract][Full Text] [Related]
8. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome.
Venkat-Raman N; Backos M; Teoh TG; Lo WT; Regan L
Obstet Gynecol; 2001 Aug; 98(2):235-42. PubMed ID: 11506839
[TBL] [Abstract][Full Text] [Related]
9. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome.
Bertolaccini ML; Contento G; Lennen R; Sanna G; Blower PJ; Ma MT; Sunassee K; Girardi G
J Autoimmun; 2016 Dec; 75():30-38. PubMed ID: 27160365
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid syndrome in obstetrics.
Kemp M; Thomas W
Lupus; 2018 Oct; 27(1_suppl):28-31. PubMed ID: 30452326
[TBL] [Abstract][Full Text] [Related]
11. [Preeclampsia and antiphospholipid syndrome. Uterine artery Doppler evaluation].
Carbillon L; Uzan M; Kettaneh A; Letellier E; Stirnemann J; Perrot N; Tigaizin A; Fain O
Rev Med Interne; 2006 Feb; 27(2):111-6. PubMed ID: 16364508
[TBL] [Abstract][Full Text] [Related]
12. Managing antiphospholipid syndrome in pregnancy.
Schreiber K; Hunt BJ
Thromb Res; 2019 Sep; 181 Suppl 1():S41-S46. PubMed ID: 31477227
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of uterine artery velocity waveforms in pregnancies complicated by systemic lupus erythematosus and the antiphospholipid syndrome.
Benifla JL; Tchobroutsky C; Uzan M; Sultan Y; Weill BJ; Laumond-Barny S
Fetal Diagn Ther; 1992; 7(3-4):195-202. PubMed ID: 1492909
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study.
Fischer-Betz R; Specker C; Brinks R; Schneider M
Lupus; 2012 Oct; 21(11):1183-9. PubMed ID: 22685017
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of obstetrical antiphospholipid syndrome: where do we stand?
Marchetti T; Cohen M; Gris JC; de Moerloose P
Pol Arch Med Wewn; 2013; 123(12):713-20. PubMed ID: 24382555
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
[TBL] [Abstract][Full Text] [Related]
18. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
[TBL] [Abstract][Full Text] [Related]
19. [Pregnancy outcome in 54 patients with antiphospholipid syndrome: a retrospective clinical study].
Zheng XJ; Deng XL; Liu XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 46(2):323-8. PubMed ID: 24743831
[TBL] [Abstract][Full Text] [Related]
20. What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?
Latino JO; Udry S; Wingeyer SP; Romero DF; Micone P; de Larrañaga G
Immunol Res; 2018 Oct; 66(5):577-583. PubMed ID: 30159862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
